Dominic Stone
Prascend (pergolide mesylate) is a medication used to treat horses with pituitary pars intermedia dysfunction (PPID), also known as Cushing's disease. PPID is a common endocrine disorder that can cause various problems in horses, including abnormal hair coat, increased thirst and urination, weight loss, muscle wasting, abdominal wall weakness, and insulin resistance. While Prascend is considered the most proven treatment for PPID, it has been reported to cause loss of appetite, weight loss, lack of energy, and behavioral changes in horses. Some owners have also reported that their horses appear 'depressed' after starting Prascend treatment. So, does Prascend cause muscle weakness in horses?
| Characteristics | Values |
|---|---|
| What is Prascend used for? | Prascend is used to treat Pituitary Pars Intermedia Dysfunction (PPID), previously known as Cushing's disease, in horses. |
| How does it work? | Prascend is a dopamine agonist that binds to receptors on neurons and increases dopaminergic activity in the brain. It also inhibits the excessive release of adrenocorticotropic hormone (ACTH), beta-endorphin, and melanocyte-stimulating hormone. |
| Does it cause muscle weakness? | While Prascend is used to treat muscle wasting, it may cause weight loss and lack of energy, which could be associated with muscle weakness. |
| What are the other side effects? | Prascend may cause loss of appetite, lethargy, behavioural changes, eye irritation, dizziness, low blood pressure, and nausea. |
Explore related products
What You'll Learn
Prascend treats muscle wasting in horses with PPID
Pituitary Pars Intermedia Dysfunction (PPID), or Equine Cushing's disease, is a common endocrine disorder in horses. It is caused by a benign tumour or gross enlargement of the pituitary gland, which regulates hormone levels in the blood. This can lead to muscle wasting, abdominal wall weakness, insulin resistance, and other issues. While there is no cure for PPID, its symptoms can be managed through medication and proper care.
Prascend (pergolide mesylate) is a medication used to treat PPID in horses. It is a dopamine agonist, which means it binds to receptors on neurons and increases dopaminergic activity in the brain. By mimicking the effects of dopamine, pergolide counteracts some of the effects of PPID and inhibits the excessive release of certain hormones. This can minimise symptoms and slow disease progression. Clinical trials show that pergolide promotes normal hair growth and alleviates muscle wasting in affected horses.
Prascend is available in tablet form and is administered orally to horses. The recommended starting dose is 2 mcg/kg once daily, which can be adjusted to effect, not exceeding 4 mcg/kg daily. It is important to consult with a veterinarian to determine the appropriate dosage for your horse. Prascend has been shown to improve the quality of life for horses with PPID, with 75-100% of treated horses experiencing an improvement in symptoms.
While Prascend is generally well-tolerated, it may cause side effects such as reduced appetite, weight loss, lack of energy, and behavioural changes. Most cases of reduced appetite are mild, but if severe, a temporary dose reduction may be necessary. Other reported adverse events in horses treated with Prascend include aggression, hyperactivity, elevated liver enzymes, and thrombocytopenia. It is important to store Prascend securely and out of reach of other animals to prevent accidental ingestion or overdose.
In summary, Prascend (pergolide mesylate) is a proven and effective treatment for horses with PPID, helping to manage symptoms such as muscle wasting and improving the overall quality of life for affected horses. While Prascend may cause some side effects, these can often be managed by adjusting the dosage under the guidance of a veterinarian.
Stress and Muscle Pain: What's the Link?
You may want to see also
Prascend may cause weight loss and lack of energy
Prascend is the brand name for the medication pergolide mesylate, which is used to treat horses with pituitary pars intermedia dysfunction (PPID), also known as Cushing's disease. This common endocrine disorder can cause a variety of problems for horses, including delayed shedding, loss of muscle mass, abdominal wall weakness, and increased coat length.
While Prascend is the most proven treatment available to control the clinical signs associated with PPID, it may cause some side effects in horses, including weight loss and lack of energy. Treatment with Prascend may also result in a loss of appetite, which can lead to weight loss if not managed properly. In most cases, the loss of appetite is mild, and adverse reactions can usually be managed by adjusting the dosage or reducing it temporarily.
The active ingredient in Prascend, pergolide, is a type of molecule that acts as a dopamine receptor agonist or activator. By replacing the absent dopamine in the horse's brain, Prascend can help regulate moods and put a stop to the overproduction of hormones caused by PPID. However, in some cases, horses starting on this treatment may show drastic changes in their behaviour, including general lethargy, appearing 'depressed', and other behavioural changes.
It is important to note that Prascend is only intended for use in horses and has not been evaluated for breeding, pregnant, or lactating horses. Pregnant or lactating women should wear gloves when administering this product and store it separately from human medicinal products. Additionally, Prascend tablets should not be crushed due to the potential for increased human exposure if accidentally ingested.
Consult with your veterinarian to determine the appropriate dosage and to discuss any concerns about administering Prascend to your horse.
How Muscle Tightness Leads to Tailbone Pain
You may want to see also
Prascend is not evaluated for pregnant or lactating horses
Prascend® (pergolide mesylate) is a medication used to treat horses with pituitary pars intermedia dysfunction (PPID), which is also known as Equine Cushing's disease. It is a dopamine agonist, meaning it binds to receptors on neurons and increases dopaminergic activity in the brain. This helps to manage the symptoms of PPID, including abnormal hair coat, increased thirst and urination, weight loss, and muscle wasting.
While Prascend has proven to be an effective treatment for PPID in horses, it has not been evaluated for use in breeding, pregnant, or lactating horses. The effects of pergolide mesylate on these specific groups of horses are unknown, and there are concerns that it may interfere with reproductive functions such as lactation. As a result, it is important to consult with a veterinarian before administering Prascend to breeding, pregnant, or lactating horses.
The safety of Prascend for horses in these specific groups has not been established, and it is always important to take precautions when dealing with any medication during pregnancy or lactation. Pregnant or lactating women who are administering Prascend to horses are advised to wear gloves to avoid any potential risks associated with exposure to the product.
Additionally, it is worth noting that Prascend is only intended for use in horses and should not be ingested by humans or other animals. Accidental ingestion by humans or other animals can lead to adverse effects, including emesis, dizziness, lethargy, and low blood pressure. Therefore, it is crucial to store Prascend securely and separately from other medicinal products to prevent any accidental ingestion or overdose.
In summary, while Prascend is a trusted treatment for PPID in horses, it has not been specifically evaluated for pregnant or lactating horses. The potential effects on reproductive functions and the safety profile in these groups are unknown. As such, it is important to exercise caution and consult with a veterinarian before administering Prascend to breeding, pregnant, or lactating horses.
Labetalol: Understanding Muscle Cramps and Their Causes
You may want to see also
Prascend may cause mild loss of appetite
Prascend (pergolide mesylate) is a medication used to treat horses with pituitary pars intermedia dysfunction (PPID), also known as Equine Cushing's disease. This common endocrine disorder can cause various problems in horses, including muscle wasting and loss of muscle mass. While Prascend is the most proven treatment available to control the clinical signs associated with PPID, it may cause mild loss of appetite in horses.
Pituitary pars intermedia dysfunction (PPID) is a common endocrine disorder in horses that affects the pituitary gland, which is responsible for maintaining appropriate hormone levels in the blood. When the pituitary gland isn't working properly, the body can undergo drastic changes due to unregulated hormones. PPID can cause a variety of issues in horses, including delayed shedding, abnormal hair coat, increased thirst and urination, weight loss, muscle wasting, and loss of muscle mass.
Prascend, the brand name for pergolide mesylate, is derived from ergotamine, a natural compound found in the ergot fungus. It acts as a dopamine agonist, binding to receptors on neurons and increasing dopaminergic activity in the brain. By mimicking dopamine, Prascend counteracts some of PPID's effects and inhibits the excessive release of certain hormones. This helps minimize symptoms and slow down disease progression.
While Prascend is highly effective in treating PPID, it may cause mild loss of appetite in horses. Most cases of loss of appetite are mild, but if severe, a temporary dose reduction may be necessary. Weight loss, lack of energy, and behavioural changes may also occur. It is important to consult with a veterinarian to determine the appropriate dosage and monitor any side effects.
Horse owners should be cautious when administering Prascend tablets to ensure their horses receive the full medication. The tablets are small and can easily be lost within the horse's feed or bedding. Some recommended methods for administering Prascend include hiding the medication in low-sugar treats or pill capsules, dissolving the tablets in water and adding it to soaked feed, or syringing the solution directly into the horse's mouth.
Understanding Charlie Horses: Causes and Prevention
You may want to see also
Prascend is contraindicated for horses with hypersensitivity to pergolide mesylate
Prascend® (pergolide mesylate) is a medication used to treat horses with pituitary pars intermedia dysfunction (PPID), previously referred to as Cushing's disease. This common endocrine disorder can cause abdominal wall weakness, weight loss, muscle wasting, and loss of muscle mass. While Prascend helps alleviate these symptoms, it is contraindicated for horses with hypersensitivity to pergolide mesylate or other ergot derivatives.
Pituitary pars intermedia dysfunction (PPID) is a common endocrine disorder in horses, affecting the pituitary gland's ability to regulate hormone levels in the blood. This can lead to various problems, including abnormal hair coat, increased thirst and urination, weight loss, muscle wasting, and loss of muscle mass. By acting as a dopamine agonist, Prascend helps to manage the symptoms of PPID and slow disease progression. Clinical trials have shown that Prascend promotes normal hair growth and reduces muscle wasting in affected horses.
However, despite its effectiveness, Prascend is not suitable for all horses. It is contraindicated for horses with hypersensitivity to pergolide mesylate or other ergot derivatives. This means that horses with an allergic or adverse reaction to pergolide mesylate or similar substances should not be given Prascend. The potential for hypersensitivity reactions highlights the importance of careful veterinary evaluation and monitoring when administering Prascend to horses with PPID.
The contraindication for horses with hypersensitivity to pergolide mesylate is an important safety precaution. Horses with PPID may already experience weight loss and muscle wasting, and administering Prascend to hypersensitive individuals could potentially exacerbate these issues. Additionally, Prascend may cause side effects such as reduced appetite, weight loss, and behavioural changes, which could further compromise the health and well-being of hypersensitive horses.
In summary, Prascend is a valuable treatment option for managing PPID in horses, but it should be used with caution and under veterinary supervision. The contraindication for horses with hypersensitivity to pergolide mesylate is crucial for ensuring the safe and effective use of this medication, helping to minimize potential adverse reactions and prioritize the health and welfare of affected horses.
Salt Deficiency: The Cause of Your Muscle Cramps?
You may want to see also
Frequently asked questions
Prascend is used to treat Pituitary Pars Intermedia Dysfunction (PPID) in horses. PPID can cause muscle wasting and loss of muscle mass. Prascend is proven to alleviate muscle wasting and reduce the clinical signs of PPID.
Prascend is a medication used to treat horses with PPID, previously known as Equine Cushing’s disease. It is a dopamine agonist that binds to receptors on neurons and increases dopaminergic activity in the brain.
Prascend may cause loss of appetite, weight loss, lack of energy, and behavioural changes. Most cases of loss of appetite are mild, but if severe, a temporary dose reduction may be necessary.
Prascend is available in tablet form and is administered orally to horses. It should not be crushed due to the potential for increased human exposure. Consult with your veterinarian to determine the appropriate dosage for your horse.
Prascend is for use in horses only and has not been evaluated in breeding, pregnant, or lactating horses. It should be kept out of the reach of other animals to prevent accidental ingestion or overdose. Pregnant or lactating women should wear gloves when administering this product.
